Author

George Zhou

Harvard UniversityORCID 0000-0002-1345-2634Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:machine learning (classical)· 2 Research Focus:benchmarking· 1 Research Focus:differential expression· 1 Approach:statistical model· 1

Frequent Co-Authors

Artem SokoloviD· 2 shared Clemens B. HugiD· 2 shared Mark W. AlbersiD· 2 shared Peter Karl SorgeriD· 2 shared Steve RodrigueziD· 2 shared Alexander Chung· 1 shared Aslı ŞahiniD· 1 shared Bradley T. HymaniD· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Artem SokolovORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintJun 4, 2024

TYK2 as a novel therapeutic target in Alzheimer Disease

Laura E. König, Steve Rodriguez, Clemens B. Hug…·Mark W. Albers

The paper identifies TYK2 as a potential therapeutic target for neurodegenerative diseases by linking cdsRNA-induced inflammation to interferon signaling and demonstrating protective effects of TYK2 inhibitors.

6 citations

humanbulk RNA-seq

𝕏 PostBluesky

NeuroscienceNature CommunicationsPeer-reviewedFeb 15, 2021

Machine Learning Identifies Novel Candidates for DrugRepurposing in Alzheimer's Disease

Steve Rodriguez, Clemens B. Hug, Petar V. Todorov…·Artem Sokolov

The paper presents a machine learning framework to identify FDA-approved drugs for repurposing in Alzheimer's Disease by analyzing gene lists associated with disease severity and molecular mechanisms.

299 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky